logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 부산지방법원 2014.06.11 2013고단8557
약사법위반
Text

The sentence of punishment against the Defendants shall be suspended.

Reasons

Punishment of the crime

Defendant

A is an employee in charge of computer processing of the F Pharmacy in Busan Northern-gu E, and the defendant B is an operator of the above pharmacy.

No person other than a pharmacy founder, including a pharmacist or herb pharmacist working for the relevant pharmacy, shall sell or acquire drugs for the purpose of sale.

Nevertheless, at around 17:04 on December 22, 2012, Defendant A, without a pharmacist’s license, sold in 3,000 a copy containing 10 notice of the Jin-Control Bank’s over-the-counter drugs, an over-the-counter drug to female customers. Defendant B, an employee of the Defendant, committed such a violation in relation to the Defendant’s business at the time and place above.

Summary of Evidence

1. Legal statement of witness G;

1. A written accusation;

1. Application of Acts and subordinate statutes to certificates of confirmation, pharmacy registration ledger, and pharmacy establishment registration certificate;

1. Article 93 (1) 7 of the Pharmaceutical Affairs Act and Article 44 (1) (Selection of Fine) of the same Act: Defendant B: Articles 97, 93 (1) 7 and 44 (1) of the Pharmaceutical Affairs Act;

1. Defendant A who is to suspend the sentence: Fine of KRW 1,000,000: fine of KRW 2,000,000; and

1. Articles 70 and 69 (2) of the Criminal Act (100,000 won per day) of the Criminal Act for the detention in a workhouse;

1. Article 59(1) of the Criminal Code of the Suspension of Sentence (Article 59(1) of the Criminal Code (Article 59(1) of the Criminal Code (Article 59(1) of the Criminal Code (Article 59(1) of the Criminal Code provides that there are no criminal records other than the one-time suspension of indictment; a video recorder is a so-called “Pamper” and has the aspect of inducing the Defendants to commit a crime to detect and report a person who violated the Pharmaceutical Affairs

arrow